NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.729
+0.068 (10.26%)
At close: Nov 20, 2024, 4:00 PM
0.670
-0.059 (-8.07%)
After-hours: Nov 20, 2024, 4:18 PM EST
NMTC Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Revenue | 3.92 | 3.41 | 2.12 | 0.24 | 1.93 | - | |
| Revenue Growth (YoY) | -16.13% | 60.73% | 772.60% | -87.39% | - | - | |
| Cost of Revenue | 8.52 | 8.44 | 5.17 | 4.2 | 2.08 | 1.53 | |
| Gross Profit | -4.6 | -5.03 | -3.05 | -3.96 | -0.15 | -1.53 | |
| Selling, General & Admin | 7.64 | 6.93 | 6.98 | 6.26 | 4.75 | 4.28 | |
| Operating Expenses | 7.64 | 6.93 | 6.98 | 6.26 | 4.75 | 4.28 | |
| Operating Income | -12.24 | -11.96 | -10.03 | -10.22 | -4.9 | -5.81 | |
| Interest Expense | -0.06 | - | - | -0 | -7.52 | -0.28 | |
| Other Non Operating Income (Expenses) | 0.1 | 0.1 | 0.03 | -0.01 | 0.8 | -0.13 | |
| EBT Excluding Unusual Items | -12.2 | -11.86 | -10 | -10.23 | -11.62 | -6.23 | |
| Legal Settlements | - | - | - | 0.2 | - | - | |
| Other Unusual Items | 0.09 | - | - | 0.08 | -2.02 | -0.55 | |
| Pretax Income | -12.1 | -11.86 | -10 | -9.95 | -13.64 | -6.78 | |
| Net Income | -12.1 | -11.86 | -10 | -9.95 | -13.64 | -6.78 | |
| Net Income to Common | -12.1 | -11.86 | -10 | -9.95 | -13.64 | -6.78 | |
| Shares Outstanding (Basic) | 25 | 18 | 16 | 11 | 5 | 4 | |
| Shares Outstanding (Diluted) | 25 | 18 | 16 | 11 | 5 | 4 | |
| Shares Change (YoY) | 49.78% | 13.27% | 49.56% | 97.52% | 37.01% | 43.18% | |
| EPS (Basic) | -0.49 | -0.65 | -0.63 | -0.93 | -2.52 | -1.72 | |
| EPS (Diluted) | -0.49 | -0.65 | -0.63 | -0.93 | -2.52 | -1.72 | |
| Free Cash Flow | -11.39 | -13.27 | -7.79 | -8.67 | -3.55 | -5.45 | |
| Free Cash Flow Per Share | -0.46 | -0.73 | -0.49 | -0.81 | -0.66 | -1.38 | |
| Gross Margin | -117.24% | -147.58% | -143.93% | - | -7.75% | - | |
| Operating Margin | -311.92% | -350.84% | -473.14% | -4205.75% | -254.46% | - | |
| Profit Margin | -308.54% | -348.03% | -471.67% | -4094.60% | -708.00% | - | |
| Free Cash Flow Margin | -290.34% | -389.45% | -367.67% | -3568.48% | -184.15% | - | |
| EBITDA | -11.99 | -11.76 | -9.91 | -10.14 | -4.85 | -5.79 | |
| EBITDA Margin | - | - | - | - | -251.98% | - | |
| D&A For EBITDA | 0.25 | 0.2 | 0.12 | 0.08 | 0.05 | 0.03 | |
| EBIT | -12.24 | -11.96 | -10.03 | -10.22 | -4.9 | -5.81 | |
| EBIT Margin | - | - | - | - | -254.46% | - | |
| Advertising Expenses | - | 0.17 | 0.27 | 0.34 | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.